Back to Search
ZHIHONG GUO, M.D.
M.D.
Psychiatry Physician
NPI: 1326208984IndividualAccepts Medicare
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
D81268(MD)
CMS Specialties
PrimaryPSYCHIATRY
Education
OTHER
Class of 1992
Research & Publications (20)
A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth.
PMID 19244107·Cancer Res·2009
7-preclinical
Leptin-mediated cell survival signaling in hippocampal neurons mediated by JAK STAT3 and mitochondrial stabilization.
PMID 17993459·J Biol Chem·2008
7-preclinical
Regulation of androgen receptor activity by tyrosine phosphorylation.
PMID 17045208·Cancer Cell·2006
4-observational
Bone marrow transplantation reveals roles for brain macrophage/microglia TNF signaling and nitric oxide production in excitotoxic neuronal death.
PMID 15626822·Neuromolecular Med·2004
7-preclinical
CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer.
PMID 15034568·Nat Med·2004
7-preclinical
Iodoacetate protects hippocampal neurons against excitotoxic and oxidative injury: involvement of heat-shock proteins and Bcl-2.
PMID 11677264·J Neurochem·2001
7-preclinical
Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy.
PMID 11448911·Clin Cancer Res·2001
8-other
In vivo 2-deoxyglucose administration preserves glucose and glutamate transport and mitochondrial function in cortical synaptic terminals after exposure to amyloid beta-peptide and iron: evidence for a stress response.
PMID 11031093·Exp Neurol·2000
7-preclinical
DNA (cytosine-5)-methyltransferase 1 as a mediator of mutant p53-determined p16(ink4A) down-regulation.
PMID 18038118·J Biomed Sci·2008
8-other
De novo induction of a cancer/testis antigen by 5-aza-2'-deoxycytidine augments adoptive immunotherapy in a murine tumor model.
PMID 16424047·Cancer Res·2006
7-preclinical
Glycosylphosphatidylinositols are potential targets for the development of novel inhibitors for aerolysin-type of pore-forming bacterial toxins.
PMID 19557762·Med Res Rev·2010
6-review
The combined administration of partially HLA-matched irradiated allogeneic lymphocytes and thalidomide in advanced renal-cell carcinoma: a case report.
PMID 19533420·Med Oncol·2010
5-case
In vitro development of goat parthenogenetic and somatic cell nuclear transfer embryos derived from different activation protocols.
PMID 19500446·Zygote·2010
7-preclinical
Pelvic reconstruction with a combined hemipelvic prostheses after resection of primary malignant tumor.
PMID 19467585·Surg Oncol·2010
8-other
Blockade of spinal nerves attenuates myocardial apoptosis in acute myocardial ischaemia/infarction in rats.
PMID 19606047·Eur J Anaesthesiol·2010
7-preclinical
The bioactive metabolites of the mangrove endophytic fungus Talaromyces sp. ZH-154 isolated from Kandelia candel (L.) Druce.
PMID 19670161·Planta Med·2010
8-other
Tribble 3, a novel oxidized low-density lipoprotein-inducible gene, is induced via the activating transcription factor 4-C/EBP homologous protein pathway.
PMID 19566842·Clin Exp Pharmacol Physiol·2010
8-other
A retrospective cohort study of nasopharyngeal adenocarcinoma: a rare histological type of nasopharyngeal cancer.
PMID 19673979·Clin Otolaryngol·2009
8-other
Disturbance of circulating ghrelin and obestatin in chronic heart failure patients especially in those with cachexia.
PMID 19666068·Peptides·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6501 N CHARLES ST
TOWSON, MD 21204 - Phone
- (410) 938-3000
Quick Facts
- NPI
- 1326208984
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 34
- Publications
- 20
Are you this provider?
Claim Your Profile